
---
title: '司太立：碘帕醇注射液拟中选第七批全国药品集中采购'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=6471'
author: 证券时报网
comments: false
date: Tue, 12 Jul 2022 21:42:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=6471'
---

<div>   
<p>证券时报e公司讯，<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS603520" style="color: #2f67d1;text-decoration: none;" code="603520" target="_blank">司太立</a>(603520)7月12日晚间公告，控股子公司上海<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS603520" style="color: #2f67d1;text-decoration: none;" code="603520" target="_blank">司太立</a>参加了联合采购办公室组织的第七批全国药品集中采购的投标工作，其中上海<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS603520" style="color: #2f67d1;text-decoration: none;" code="603520" target="_blank">司太立</a>产品碘帕醇注射液拟中选本次集中采购。</p>

                  
</div>
            